Nanobarcoding: Detecting nanoparticles in biological samples using in situ polymerase chain reaction

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 5625-5639

  Eustaquio, Trisha ^a   Leary, James F ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

DNA functionalized nanoparticles; In situ PCR; Nanomedicine; Single cell

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ARTICLE; CONFOCAL MICROSCOPY; CONJUGATION; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; IN VITRO STUDY; INTRACELLULAR TRANSPORT; LIGHT SCATTERING; MOLECULAR IMAGING; NANOANALYSIS; PARTICLE SIZE; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WART VIRUS; ZETA POTENTIAL;

CARBOCYANINES; HELA CELLS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MAGNETITE NANOPARTICLES; MICROSCOPY, FLUORESCENCE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING;

HUMAN PAPILLOMAVIRUS;

EID: 84870360284     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S37433     Document Type: Article

References (66)

1. Haglund E, Seale-Goldsmith MM, Leary JF. Design of multifunctional nanomedical systems. Ann Biomed Eng. 2009;37(10):2048-2063.
2. Seale-Goldsmith MM, Leary JF. Nanobiosystems. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2009;1(5):553-567.
3. von Eschenbach AC. Nanotechnology: A Report of the US Food and Drug Administration Nanotechnology Task Force. 2007; Available from: http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/Nanotechnology/ucm110856.pdf. Accessed July 2, 2012.
4. Elsaesser A, Taylor A, de Yanes GS, etal. Quantification of nanoparticle uptake by cells using microscopical and analytical techniques. Nanomedicine (Lond). 2010;5(9):1447-1457.
5. Alivisatos AP, Gu W, Larabell C. Quantum dots as cellular probes. Annu Rev Biomed Eng. 2005;7:55-76.
6. Ballou B. Quantum dot surfaces for use in vivo and in vitro. Curr Top Dev Biol. 2005;70:103-120.
7. Aviv H, Bartling S, Kieslling F, Margel S. Radiopaque iodinated copolymeric nanoparticles for X-ray imaging applications. Biomaterials. 2009;30(29):5610-5616.
8. Rahn H, Odenbach S. X-ray microcomputed tomography as a tool for the investigation of the biodistribution of magnetic nanoparticles. Nanomedicine. 2009;4(8):981-990.
9. Cho CF, Ablack A, Leong HS, Zijlstra A, Lewis J. Evaluation of nanoparticle uptake in tumors in real time using intravital imaging. J Vis Exp. 2011;52:2808.
10. Müller K, Skepper JN, Tang TY, etal. Atorvastatin and uptake of ultra-small superparamagnetic iron oxide nanoparticles (Ferumoxtran-10) in human monocyte-macrophages: implications for magnetic resonance imaging. Biomaterials. 2008;29(17):2656-2662.
11. Rahimi M, Wadajkar A, Subramanian K, etal. In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery. Nanomedicine. 2010;6(5):672-680.
12. Gultepe E, Reynoso FJ, Jhaveri A, etal. Monitoring of magnetic targeting to tumor vasculature through MRI and biodistribution. Nanomedicine (Lond). 2010;5(8):1173-1182.
13. Haglund EM, Seale-Goldsmith MM, Dhawan D, etal. Peptide targeting of quantum dots to human breast cancer cells. Proc SPIE. 2008;6866:68660S1-68660S8.
14. Al-Hajaj NA, Moquin A, Neibert KD, Soliman GM, Winnik FM, Maysinger D. Short ligands affect modes of QD uptake and elimination in human cells. ACS Nano. 2011;5(6):4909-4918.
15. Meng H, Yang S, Li Z, etal. Aspect ratio determines the quantity of mesoporous silica nanoparticle uptake by a small GTPase-dependent macropinocytosis mechanism. ACS Nano. 2011;5(6):4434-4447.
16. Kumar A, Pandey AK, Singh SS, Shanker R, Dhawan A. A flow cytometric method to assess nanoparticle uptake in bacteria. Cytometry A. 2011;79(9):707-712.
17. 2nanoparticles in cells by flow cytometry. Cytometry A. 2010;77(7):677-685.
18. Choi J, Zheng Q, Katz HE, Guilarte TR. Silica-based nanoparticle uptake and cellular response by primary microglia. Environ Health Perspect. 2010;118(5):589-595.
19. Corbalan JJ, Medina C, Jacoby A, Malinski T, Radomski MW. Amorphous silica nanoparticles trigger nitric oxide/peroxynitrite imbalance in human endothelial cells: inflammatory and cytotoxic effects. Int J Nanomedicine. 2011;6:2821-2835.
20. Peckys DB, de Jonge N. Visualizing gold nanoparticle uptake in live cells with liquid scanning transmission electron microscopy. Nano Lett. 2011;11(4):1733-1738.
21. Zhong L, Zeng G, Lu X, etal. NSOM/QD-based direct visualization of CD3-induced and CD28-enhanced nanospatial coclustering of TCR and coreceptor in nanodomains in T cell activation. PLoS One. 2009;4(6):e5945.
22. Zhong L, Zhang Z, Lu X, etal. NSOM/QD-based fluorescence-topographic image fusion directly reveals nano-spatial peak-valley polarities of CD69 and CD71 activation molecules on cell-membrane fluctuations during T-cell activation. Immunol Lett. 2011;140(1-2):44-51.
23. Chang BJ, Lin SH, Chou LJ, Chiang SY. Subdiffraction scattered light imaging of gold nanoparticles using structured illumination. Opt Lett. 2011;36(24):4773-4775.
24. Schübbe S, Cavelius C, Schumann C, Koch M, Kraegeloh A. STED microscopy to monitor agglomeration of silica particles inside A549 cells. Adv Eng Mater. 2010;12(5):417-422.
25. Gupta AK, Berry C, Gupta M, Curtis A. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis. IEEE Trans Nanobioscience. 2003;2(4):255-261.
26. Gupta AK, Gupta M. Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles. Biomaterials. 2005;26(13):1565-1573.
27. Huang X, Peng X, Wang Y, Shin DM, El-Sayed MA, Nie S. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano. 2010;4(10):5887-5896.
28. Zhang X, Xing JZ, Chen J, etal. Enhanced radiation sensitivity in prostate cancer by gold-nanoparticles. Clin Invest Med. 2008;31(3): E160-E167.
29. Zhu ZJ, Ghosh PS, Miranda OR, Vachet RW, Rotello VM. Multiplexed screening of cellular uptake of gold nanoparticles using laser desorption/ionization mass spectrometry. J Am Chem Soc. 2008;130(43):14139-14143.
30. Deering CE, Tadjiki S, Assemi S, Miller JD, Yost GS, Veranth JM. A novel method to detect unlabeled inorganic nanoparticles and submicron particles in tissue by sedimentation field-flow fractionation. Part Fibre Toxicol. 2008;5:18.
31. Chavanpatil MD, Khdair A, Panyam J. Surfactant-polymer nanoparticles: a novel platform for sustained and enhanced cellular delivery of water-soluble molecules. Pharm Res. 2007;24(4):803-810.
32. Davda J, Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int J Pharm. 2002;233(1-2):51-59.
33. Ece Gamsiz D, Shah LK, Devalapally H, Amiji MM, Carrier RL. A model predicting delivery of saquinavir in nanoparticles to human monocyte/macrophage (Mo/Mac) cells. Biotechnol Bioeng. 2008;101(5):1072-1082.
34. Lin A, Chen J, Liu Y, etal. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting. Drug Dev Ind Pharm. 2009;35(11):1348-1355.
35. DiCarlo D, Lee LP. Dynamic single cell analysis for quantitative biology. Anal Chem. 2006;78(23):7918-7925.
36. Nuovo GJ. PCR in Situ Hybridization: Protocols and Applications. 3rd ed. Philadelphia: Lippincott-Raven; 1997.
37. Bagasra O. Protocols for the in situ PCR-amplification and detection of mRNA and DNA sequences. Nat Protoc. 2007;2(11):2782-2795.
38. Bagasra O. In situ polymerase chain reaction and hybridization to detect low-abundance nucleic acid targets. In: Current Protocols in Molecular Biology. Hoboken, NJ: John Wiley & Sons, Inc.; 2001.
39. Eustaquio T, Leary JF, inventors. Single nanoparticle detection by DNA barcoding for biodistribution studies in nanomedicine. United States patent application 61/363.898; filed 2010.
40. Eustaquio T, Leary JF. Nanobarcoding: a novel method of single nanoparticle detection in cells and tissues for nanomedical biodistribution studies. Proc SPIE. 2011;8099:80990V-1-80990V-13.
41. Eustaquio T, Cooper CL, Leary JF. Single-cell imaging detection of nanobarcoded nanoparticle biodistributions in tissues for nanomedicine. Proc SPIE. 2011;7910:79100O-1-79100O-11.
42. Lesnikova I, Lidang M, Hamilton-Dutoit S, Koch J. Rapid, sensitive, type specific PCR detection of the E7 region of human papillomavirus type 16 and 18 from paraffin embedded sections of cervical carcinoma. Infect Agent Cancer. 2010;5(2):1-5.
43. Seferos DS, Prigodich AE, Giljohann DA, Patel PC, Mirkin CA. Polyvalent DNA nanoparticle conjugates stabilize nucleic acids. Nano Lett. 2009;9(1):308-311.
44. Leroux JC, De Jaeghere F, Anner B, Doelker E, Gurny R. An investigation on the role of plasma and serum opsonins on the internalization of biodegradable poly(D, L-lactic acid) nanoparticles by human monocytes. Life Sci. 1995;57(7):695-703.
45. Sharma VK. Aggregation and toxicity of titanium dioxide nanoparticles in aquatic environment-a review. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2009;44(14):1485-1495.
46. Cutler JI, Zheng D, Xu XY, Giljohann DA, Mirkin CA. Polyvalent oligonucleotide iron oxide nanoparticle "click" conjugates. Nano Lett. 2010;10(4):1477-1480.
47. Giljohann DA, Seferos DS, Patel PC, Millstone JE, Rosi NL, Mirkin CA. Oligonucleotide loading determines cellular uptake of DNA-modified gold nanoparticles. Nano Lett. 2007;7(12):3818-3821.
48. Patel PC, Giljohann DA, Daniel WL, Zheng D, Prigodich AE, Mirkin CA. Scavenger receptors mediate cellular uptake of polyvalent oligonucleotide-functionalized gold nanoparticles. Bioconjug Chem. 2010;21(12):2250-2256.
49. Long AA, Komminoth P, Lee E, Wolfe HJ. Comparison of indirect and direct in-situ polymerase chain reaction in cell preparations and tissue sections. Detection of viral DNA, gene rearrangements and chromosomal translocations. Histochemistry. 1993;99(2):151-162.
50. Wiedorn KH, Kuhl H, Galle J, Caselitz J, Vollmer E. Comparison of in-situ hybridization, direct and indirect in-situ PCR as well as tyramide signal amplification for the detection of HPV. Histochem Cell Biol. 1999;111(2):89-95.
51. Singh N, Jenkins GJ, Asadi R, Doak SH. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010:1.
52. Morel G, Raccurt M. PCR/RT-PCR in Situ Light and Electron Microscopy. Boca Raton: CRC Press; 2003.
53. Bagasra O, Hansen J. In-Situ PCR Techniques. New York: Wiley-Liss; 1997.
54. Seale MM. Design of Targeted Nanoparticles for Multifunctional Nanomedical Systems [PhD thesis]. West Lafayette: Biomedical Engineering, Purdue University; 2009.
55. Hurst SJ, Lytton-Jean AKR, Mirkin CA. Maximizing DNA loading on a range of gold nanoparticle sizes. Anal Chem. 2006;78(24):8313-8318.
56. Zwanikken JW, Guo PJ, Mirkin CA, de la Cruz MO. Local ionic environment around polyvalent nucleic acid-functionalized nanoparticles. J Phys Chem C. 2011;115(33):16368-16373.
57. Eder PS, DeVine RJ, Dagle JM, Walder JA. Substrate specificity and kinetics of degradation of antisense oligonucleotides by a 3' exonuclease in plasma. Antisense Res Dev. 1991;1(2):141-151.
58. Akhtar S, Kole R, Juliano RL. Stability of antisense DNA oligodeoxynucleotide analogs in cellular extracts and sera. Life Sci. 1991;49(24):1793-1801.
59. Gleave ME, Monia BP. Antisense therapy for cancer. Nat Rev Cancer. 2005;5(6):468-479.
60. Kim DW, Kim JH, Park M, etal. Modulation of biological processes in the nucleus by delivery of DNA oligonucleotides conjugated with gold nanoparticles. Biomaterials. 2011;32(10):2593-2604.
61. Rosi NL, Giljohann DA, Thaxton CS, Lytton-Jean AK, Han MS, Mirkin CA. Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science. 2006;312(5776):1027-1030.
62. Hurtado R, Mikawa T. Enhanced sensitivity and stability in two-color in situ hybridization by means of a novel chromagenic substrate combination. Dev Dyn. 2006;235(10):2811-2816.
63. Andras SC, Power JB, Cocking EC, Davey MR. Strategies for signal amplification in nucleic acid detection. Mol Biotechnol. 2001;19(1):29-44.
64. Werner M, Von Wasielewski R, Komminoth P. Antigen retrieval, signal amplification and intensification in immunohistochemistry. Histochem Cell Biol. 1996;105(4):253-260.
65. Merz H, Malisius R, Mannweiler S, etal. ImmunoMax. A maximized immunohistochemical method for the retrieval and enhancement of hidden antigens. Lab Invest. 1995;73(1):149-156.
66. Altshuler ML. PCR Troubleshooting: The Essential Guide. Hethersett: Caister Academic Press; 2006.